Header Logo

GREGORY A LIZEE

TitleAssociate Professor
InstitutionMD Anderson
DepartmentMelanoma Medical Oncology
Address7455 Fannin St
Houston TX 77054-1901
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chaudhri A, Lizee G, Hwu P, Rai K, Chaudhri A, Lizee G, Hwu P, Rai K. Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment. Cancer Res. 2024 Apr 01; 84(7):965-976. PMID: 38266066.
      Citations:    Fields:    Translation:HumansCells
    2. Jin Y, Miyama T, Brown A, Hayase T, Song X, Singh AK, Huang L, Flores II, McDaniel LK, Glover I, Halsey TM, Prasad R, Chapa V, Ahmed S, Zhang J, Rai K, Peterson CB, Lizee G, Karmouch J, Hayase E, Molldrem JJ, Chang CC, Tsai WB, Jenq RR. Tsyn-seq: a T cell synapse-based antigen identification platform. Cancer Immunol Res. 2024 Feb 16. PMID: 38363296.
      Citations:    Fields:    
    3. Singh S, Xiao Z, Bavisi K, Roszik J, Melendez BD, Wang Z, Cantwell MJ, Davis RE, Lizee G, Hwu P, Neelapu SS, Overwijk WW, Singh M. Correction: IL-1a Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma. J Immunol. 2024 Feb 01; 212(3):500. PMID: 38088809.
      Citations:    Fields:    
    4. Bolivar AM, Duzagac F, Deng N, Reyes-Uribe L, Chang K, Wu W, Bowen CM, Taggart MW, Thirumurthi S, Lynch PM, You YN, Rodriguez-Pascual J, Lipkin SM, Kopetz S, Scheet P, Lizee GA, Reuben A, Sinha KM, Vilar E, Bolivar AM, Duzagac F, Deng N, Reyes-Uribe L, Chang K, Wu W, Bowen CM, Taggart MW, Thirumurthi S, Lynch PM, You YN, Lipkin SM, Kopetz S, Scheet P, Lizee GA, Reuben A, Sinha KM, Vilar E. Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention. Gastroenterology. 2024 Jan 18. PMID: 38244726.
      Citations:    Fields:    
    5. Chaudhri A, Bu X, Wang Y, Gomez M, Torchia JA, Hua P, Hung SH, Davies MA, Lizee GA, von Andrian U, Hwu P, Freeman GJ. The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy. Front Immunol. 2023; 14:1237715. PMID: 37771579; PMCID: PMC10524267.
      Citations:    Fields:    Translation:Animals
    6. Chen CH, Chin RL, Hartley GP, Lea ST, Engel BJ, Hsieh CE, Prasad R, Roszik J, Shingu T, Lizee GA, Heimberger AB, Millward SW, Hu J, Hong DS, Curran MA. Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease. Neuro Oncol. 2023 08 03; 25(8):1415-1427. PMID: 36705543; PMCID: PMC10398813.
      Citations:    Fields:    Translation:HumansAnimalsCells
    7. Liang S, Jiang X, Chiu Y, Xu H, Kim KH, Lizee G, Chen K. An interpretable ML model to characterize patient-specific HLA-I antigen presentation. bioRxiv. 2023 Mar 13. PMID: 36993682; PMCID: PMC10054957.
      Citations:    
    8. Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa'ak F, Mathew A, Wang Y, Falohun A, Trinh V, Zobniw C, Spillson C, Burks JK, Awiwi M, Elsayes K, Soto LS, Melendez BD, Davies MA, Wargo J, Curry J, Yee C, Lizee G, Singh S, Sharma P, Allison JP, Hwu P, Ekmekcioglu S, Diab A. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell. 2022 05 09; 40(5):509-523.e6. PMID: 35537412; PMCID: PMC9221568.
      Citations:    Fields:    Translation:HumansAnimalsCells
    9. Sun Y, Li F, Sonnemann H, Jackson KR, Talukder AH, Katailiha AS, Lizee G. Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells. 2021 09 10; 10(9). PMID: 34572028; PMCID: PMC8469972.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    10. Li F, Deng L, Jackson KR, Talukder AH, Katailiha AS, Bradley SD, Zou Q, Chen C, Huo C, Chiu Y, Stair M, Feng W, Bagaev A, Kotlov N, Svekolkin V, Ataullakhanov R, Miheecheva N, Frenkel F, Wang Y, Zhang M, Hawke D, Han L, Zhou S, Zhang Y, Wang Z, Decker WK, Sonnemann HM, Roszik J, Forget MA, Davies MA, Bernatchez C, Yee C, Bassett R, Hwu P, Du X, Lizee G. Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations. J Immunother Cancer. 2021 07; 9(7). PMID: 34244308; PMCID: PMC8268925.
      Citations: 2     Fields:    Translation:Humans
    11. Gupta RG, Li F, Roszik J, Liz?e G. Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches. Cancer Discov. 2021 05; 11(5):1024-1039. PMID: 33722796; PMCID: PMC8102318.
      Citations: 14     Fields:    Translation:Humans
    12. Singh S, Xiao Z, Bavisi K, Roszik J, Melendez BD, Wang Z, Cantwell MJ, Davis RE, Lizee G, Hwu P, Neelapu SS, Overwijk WW, Singh M. IL-1a Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma. J Immunol. 2021 04 15; 206(8):1966-1975. PMID: 33722878; PMCID: PMC8023145.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    13. Yoshihama S, Cho SX, Yeung J, Pan X, Lizee G, Konganti K, Johnson VE, Kobayashi KS. NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy. Sci Rep. 2021 02 05; 11(1):3258. PMID: 33547395; PMCID: PMC7865024.
      Citations: 3     Fields:    Translation:Humans
    14. Peng W, Williams LJ, Xu C, Melendez B, McKenzie JA, Chen Y, Jackson HL, Voo KS, Mbofung RM, Leahey SE, Wang J, Lizee G, Tawbi HA, Davies MA, Hoos A, Smothers J, Srinivasan R, Paul EM, Yanamandra N, Hwu P. Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3K? Inhibition in PTEN Loss Melanoma. Clin Cancer Res. 2019 11 01; 25(21):6406-6416. PMID: 31371342; PMCID: PMC7232853.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    15. Zhang M, Roszik J, Williams LJ, Peng X, Chiu Y, Tsou CC, Talukder A, Forget MA, Haymaker C, Bernatchez C, Han L, Tsang YH, Kong K, Xu X, Scott KL, Lizee G, Liang H, Mills GB, Hwu P, Fritsche J, Hoffgaard F, Goldfinger V, Schoor O, Singh-Jasuja H, Weinschenk T. RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nat Commun. 2018 09 25; 9(1):3919. PMID: 30254248; PMCID: PMC6156571.
      Citations: 43     Fields:    Translation:HumansCells
    16. Wolff RA, Wang-Gillam A, Alvarez H, Engle D, Hou S, Groff AF, San Lucas A, Bernard V, Allenson K, Castillo J, Kim D, Mulu F, Huang J, Stephens B, Wistuba II, Katz M, Varadhachary G, Park Y, Hicks J, Chinnaiyan A, Scampavia L, Spicer T, Gerhardinger C, Maitra A, Tuveson D, Rinn J, Lizee G, Yee C, Levine AJ, Tiriac H. Dynamic changes during the treatment of pancreatic cancer. Oncotarget. 2018 Mar 13; 9(19):14764-14790. PMID: 29599906; PMCID: PMC5871077.
      Citations: 9     Fields:    
    17. Mbofung RM, McKenzie JA, Malu S, Zhang M, Peng W, Liu C, Kuiatse I, Tieu T, Williams L, Devi S, Ashkin E, Xu C, Huang L, Zhang M, Talukder AH, Tripathi SC, Khong H, Satani N, Muller FL, Roszik J, Heffernan T, Allison JP, Lizee G, Hanash SM, Proia D, Amaria R, Davis RE, Hwu P. HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes. Nat Commun. 2017 09 06; 8(1):451. PMID: 28878208; PMCID: PMC5587668.
      Citations: 45     Fields:    Translation:HumansAnimalsCells
    18. Lyons YA, Pradeep S, Wu SY, Haemmerle M, Hansen JM, Wagner MJ, Villar-Prados A, Nagaraja AS, Dood RL, Previs RA, Hu W, Zhao Y, Mak DH, Xiao Z, Melendez BD, Lizee GA, Mercado-Uribe I, Baggerly KA, Hwu P, Liu J, Overwijk WW, Coleman RL, Sood AK. Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy. Oncotarget. 2017 Nov 14; 8(57):96496-96505. PMID: 29228548; PMCID: PMC5722500.
      Citations: 24     Fields:    
    19. Yee C, Lizee GA. Personalized Therapy: Tumor Antigen Discovery for Adoptive Cellular Therapy. Cancer J. 2017 Mar/Apr; 23(2):144-148. PMID: 28410303.
      Citations: 2     Fields:    Translation:Humans
    20. Alatrash G, Garber HR, Zhang M, Sukhumalchandra P, Qiu Y, Jakher H, Perakis AA, Becker L, Yoo SY, Dwyer KC, Coombes K, Talukder AH, John LSS, Senyukov V, Lee DA, Sergeeva A, He H, Ma Q, Armistead PM, Roszik J, Mittendorf EA, Molldrem JJ, Hawke D, Lizee G, Kornblau SM. Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target. Leukemia. 2017 01; 31(1):234-237. PMID: 27573556; PMCID: PMC5215491.
      Citations: 13     Fields:    Translation:HumansAnimals
    21. Yoshihama S, Roszik J, Downs I, Meissner TB, Vijayan S, Chapuy B, Sidiq T, Shipp MA, Lizee GA, Kobayashi KS. NLRC5/MHC class I transactivator is a target for immune evasion in cancer. Proc Natl Acad Sci U S A. 2016 May 24; 113(21):5999-6004. PMID: 27162338; PMCID: PMC4889388.
      Citations: 89     Fields:    Translation:HumansCells
    22. Bernatchez C, Cooper ZA, Wargo JA, Hwu P, Liz?e G. Novel Treatments in Development for Melanoma. Cancer Treat Res. 2016; 167:371-416. PMID: 26601872.
      Citations: 7     Fields:    Translation:HumansCells
    23. Lizee G, Schueneman AJ, Yee C. Endogenous T-Cell Therapy: Clinical Experience. Cancer J. 2015 Nov-Dec; 21(6):492-500. PMID: 26588682.
      Citations: 13     Fields:    Translation:Humans
    24. Brown WS, Khalili JS, Rodriguez-Cruz TG, Lizee G, McIntyre BW. B-Raf regulation of integrin a4?1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cells. J Biol Chem. 2014 Aug 15; 289(33):23141-23153. PMID: 24936068; PMCID: PMC4132812.
      Citations: 6     Fields:    Translation:HumansCells
    25. Vence LM, Wang C, Pappu H, Anson RE, Patel TA, Miller P, Bassett R, Lizee G, Overwijk WW, Komanduri K, Benjamin C, Alvarado G, Patel SP, Kim K, Papadopoulos NE, Bedikian AY, Homsi J, Hwu WJ, Boyd R, Radvanyi L, Hwu P. Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination. J Immunother. 2013 May; 36(4):276-86. PMID: 23603862; PMCID: PMC3799876.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    26. Frederick DT, Piris A, Cogdill AP, Cooper ZA, Lezcano C, Ferrone CR, Mitra D, Boni A, Newton LP, Liu C, Peng W, Sullivan RJ, Lawrence DP, Hodi FS, Overwijk WW, Murphy GF, Hwu P, Flaherty KT, Fisher DE, Wargo JA, Liz?e G. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013 Mar 01; 19(5):1225-31. PMID: 23307859; PMCID: PMC3752683.
      Citations: 404     Fields:    Translation:HumansCells
    27. Liu C, Peng W, Xu C, Lou Y, Zhang M, Wargo JA, Chen JQ, Li HS, Watowich SS, Yang Y, Tompers Frederick D, Cooper ZA, Mbofung RM, Whittington M, Flaherty KT, Woodman SE, Davies MA, Radvanyi LG, Overwijk WW, Hwu P, Liz?e G. BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice. Clin Cancer Res. 2013 Jan 15; 19(2):393-403. PMID: 23204132; PMCID: PMC4120472.
      Citations: 167     Fields:    Translation:HumansAnimalsCells
    28. Zhang M, Sukhumalchandra P, Enyenihi AA, St John LS, Hunsucker SA, Mittendorf EA, Sergeeva A, Ruisaard K, Al-Atrache Z, Ropp PA, Jakher H, Rodriguez-Cruz T, Lizee G, Clise-Dwyer K, Lu S, Molldrem JJ, Glish GL, Armistead PM, Alatrash G. A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia. Clin Cancer Res. 2013 Jan 01; 19(1):247-57. PMID: 23147993; PMCID: PMC3537920.
      Citations: 14     Fields:    Translation:HumansCells
    29. Overwijk WW, Radvanyi L, Gao J, Sharma P, Hwu P, Liz?e G. Harnessing the power of the immune system to target cancer. Annu Rev Med. 2013; 64:71-90. PMID: 23092383.
      Citations: 65     Fields:    Translation:Humans
    30. Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto V, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu P. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2012 Dec 15; 18(24):6758-70. PMID: 23032743; PMCID: PMC3525747.
      Citations: 177     Fields:    Translation:HumansCellsCTClinical Trials
    31. Yang Y, Liu C, Peng W, Overwijk WW, Liu Y, Woodman SE, Hwu P, Liz?e G. Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40. Blood. 2012 Nov 29; 120(23):4533-43. PMID: 22936666; PMCID: PMC3512233.
      Citations: 30     Fields:    Translation:AnimalsCells
    32. Peng W, Liu C, Xu C, Lou Y, Chen J, Yang Y, Yagita H, Overwijk WW, Radvanyi L, Hwu P, Liz?e G. PD-1 blockade enhances T-cell migration to tumors by elevating IFN-? inducible chemokines. Cancer Res. 2012 Oct 15; 72(20):5209-18. PMID: 22915761; PMCID: PMC3476734.
      Citations: 185     Fields:    Translation:AnimalsCells
    33. Khalili JS, Liu S, Whittington M, Wardell S, Liu C, Zhang M, Cooper ZA, Frederick DT, Li Y, Zhang M, Joseph RW, Bernatchez C, Ekmekcioglu S, Grimm E, Radvanyi LG, Davis RE, Davies MA, Wargo JA, Hwu P, Rodr?guez-Cruz TG, Liz?e G. Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma. Clin Cancer Res. 2012 Oct 01; 18(19):5329-40. PMID: 22850568; PMCID: PMC3463754.
      Citations: 142     Fields:    Translation:HumansCells
    34. Khalili JS, Yu X, Wang J, Hayes BC, Davies MA, Lizee G, Esmaeli B, Woodman SE. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012 Aug 15; 18(16):4345-55. PMID: 22733540; PMCID: PMC3935730.
      Citations: 67     Fields:    Translation:HumansCells
    35. Alatrash G, Ono Y, Sergeeva A, Sukhumalchandra P, Zhang M, St John LS, Yang TH, Ruisaard K, Armistead PM, Mittendorf EA, He H, Qiao N, Rodriguez-Cruz T, Liang S, Clise-Dwyer K, Wieder ED, Lizee G, Lu S, Molldrem JJ. The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1. J Immunother. 2012 May; 35(4):309-20. PMID: 22495388; PMCID: PMC3326226.
      Citations: 16     Fields:    Translation:HumansCells
    36. Liu C, Lewis CM, Lou Y, Xu C, Peng W, Yang Y, Gelbard AH, Zhou D, Overwijk WW, Hwu P, Liz?e G. Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo. J Immunother. 2012 Apr; 35(3):276-82. PMID: 22421945; PMCID: PMC3860320.
      Citations: 20     Fields:    Translation:AnimalsCells
    37. Hong DS, Vence L, Falchook G, Radvanyi LG, Liu C, Goodman V, Legos JJ, Blackman S, Scarmadio A, Kurzrock R, Lizee G, Hwu P. BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency. Clin Cancer Res. 2012 Apr 15; 18(8):2326-35. PMID: 22355009.
      Citations: 45     Fields:    Translation:HumansCellsCTClinical Trials
    38. Wu RC, Liu S, Chacon JA, Wu S, Li Y, Sukhumalchandra P, Murray JL, Molldrem JJ, Hwu P, Pircher H, Radvanyi LG, Liz?e G. Detection and characterization of a novel subset of CD8?CD57? T cells in metastatic melanoma with an incompletely differentiated phenotype. Clin Cancer Res. 2012 May 01; 18(9):2465-77. PMID: 22307139; PMCID: PMC3343210.
      Citations: 10     Fields:    Translation:HumansCells
    39. Qin Y, Ekmekcioglu S, Liu P, Duncan LM, Poindexter N, Grimm EA, Liz?e G. Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma. Mol Cancer Res. 2011 Nov; 9(11):1537-50. PMID: 21954434; PMCID: PMC3387749.
      Citations: 43     Fields:    Translation:HumansCells
    40. Liu S, Khalili JS, Whittington M, Zhang M, Overwijk W, Rodr?guez-Cruz TG, Liz?e G. Natural splice variant of MHC class I cytoplasmic tail enhances dendritic cell-induced CD8+ T-cell responses and boosts anti-tumor immunity. PLoS One. 2011; 6(8):e22939. PMID: 21860662; PMCID: PMC3157908.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    41. Lou Y, Liu C, Peng W, Xu C, Ye Y, Rabinovich BA, Hailemichael Y, Gelbard A, Zhou D, Overwijk WW, Hwu P, Liz?e G. Antitumor activity mediated by CpG: the route of administration is critical. J Immunother. 2011 Apr; 34(3):279-88. PMID: 21389870; PMCID: PMC6119202.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    42. Peng W, Ye Y, Rabinovich BA, Liu C, Lou Y, Zhang M, Whittington M, Yang Y, Overwijk WW, Hwu P, Liz?e G. Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses. Clin Cancer Res. 2010 Nov 15; 16(22):5458-68. PMID: 20889916; PMCID: PMC3476703.
      Citations: 103     Fields:    Translation:AnimalsCells
    43. Liu S, Etto T, Li Y, Wu C, Fulbright OJ, Hwu P, Radvanyi L, Rodr?guez-Cruz T, Liz?e G. TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy. J Immunother. 2010 May; 33(4):371-81. PMID: 20386469.
      Citations: 2     Fields:    Translation:HumansCells
    44. Basha G, Reinicke AT, Seipp RP, Omilusik KD, Jefferies WA, Liz?e G. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells. PLoS One. 2008 Sep 19; 3(9):e3247. PMID: 18802471; PMCID: PMC2532750.
      Citations: 36     Fields:    Translation:AnimalsCells
    45. Hwang CS, Prieto VG, Diwan AH, Lizee G, Ellerhorst JA, Ekmekcioglu S, Liu P, Eton O, Kinney SA, Grimm EA, Hwu P, Kim KB. Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment. Melanoma Res. 2008 Aug; 18(4):241-5. PMID: 18626307; PMCID: PMC3880193.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    46. Liu C, Lou Y, Qin H, Liu S, Rabinovich B, Kim GJ, Wang YH, Ye Y, Sikora AG, Overwijk WW, Liu YJ, Wang G, Hwu P, Liz?e G. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest. 2008 Mar; 118(3):1165-75. PMID: 18259609; PMCID: PMC2230660.
      Citations: 129     Fields:    Translation:AnimalsCells
    47. Lee ST, Liu S, Radvanyi L, Sukhumalchandra P, Molldrem JJ, Wieder ED, Hwu P, Liu YJ, Kwak LW, Neelapu SS, Liz?e G. A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones. J Immunol Methods. 2008 Feb 29; 331(1-2):13-26. PMID: 17959194; PMCID: PMC2265521.
      Citations: 8     Fields:    Translation:HumansCells
    48. Liu S, Lou Y, Liu C, Overwijk WW, Wang G, Hwu P, Liz?e G. IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells. Int Immunol. 2007 Oct; 19(10):1213-21. PMID: 17898044.
      Citations: 33     Fields:    Translation:AnimalsCells
    49. Cantu MA, Hwu P, Liz?e G. Less yin, more yang: confronting the barriers to cancer immunotherapy. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 1):5250-5. PMID: 17875752.
      Citations: 27     Fields:    Translation:HumansCells
    50. Zhu K, Qin H, Cha SC, Neelapu SS, Overwijk W, Lizee GA, Abbruzzese JL, Hwu P, Radvanyi L, Kwak LW, Chang DZ. Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models. Vaccine. 2007 Nov 14; 25(46):7955-61. PMID: 17933439.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    51. Grover A, Kim GJ, Tschoi M, Wang G, Wunderlich JR, Rosenberg SA, Hwang ST, Hwu P, Liz?e G. Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes. Clin Cancer Res. 2006 Oct 01; 12(19):5801-8. PMID: 17020987; PMCID: PMC2174601.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    52. Zhu K, Lizee G, Cano P, Fernando-Vina M, Ji B, Abbruzzese JL, Hwu P, Radvanyi L, Chang DZ. HLA-A0201 positive pancreatic cell lines: new findings and discrepancies. Cancer Immunol Immunother. 2007 May; 56(5):719-24. PMID: 16947023.
      Citations: 1     Fields:    Translation:HumansCells
    53. Radvanyi LG, Overwijk WW, Hwu P, Liz?e G. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms. Clin Cancer Res. 2006 Aug 15; 12(16):4794-803. PMID: 16914564.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    54. Radvanyi LG, Overwijk WW, Hwu P, Liz?e G. Immunosuppression in melanoma immunotherapy: potential opportunities for intervention. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 2):2359s-2365s. PMID: 16609059.
      Citations: 11     Fields:    Translation:HumansAnimals
    55. Basha G, Jefferies WA, Liz?e G. Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation. Trends Immunol. 2005 Mar; 26(3):141-9. PMID: 15745856.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    56. Lou Y, Wang G, Kim GJ, Finkelstein SE, Feng C, Restifo NP, Hwu P, Liz?e G. Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo. Cancer Res. 2004 Sep 15; 64(18):6783-90. PMID: 15374997; PMCID: PMC2241750.
      Citations: 58     Fields:    Translation:HumansAnimalsCells
    57. Gonzales MI, Topalian SL, Liz?e G. Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells. Hum Gene Ther. 2004 Apr; 15(4):393-404. PMID: 15053864.
      Citations: 27     Fields:    Translation:HumansCells
    58. Sharkey MS, Gonzales MI, Patel S, Topalian SL, Liz?e G. CD4(+) T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutation. Cancer Res. 2004 Mar 01; 64(5):1595-9. PMID: 14996715.
      Citations: 35     Fields:    Translation:HumansCells
    59. Basha G, Tiong J, Julien JP, Tian M, Biron KE, Jefferies WA, Liz?e G. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol. 2003 Nov; 4(11):1065-73. PMID: 14566337.
      Citations: 69     Fields:    Translation:AnimalsCells
    60. Aerts JL, Gonzales MI, Chinnasamy N, Morgan RA, Topalian SL, Liz?e G. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther. 2003 Apr 10; 14(6):497-507. PMID: 12718761.
      Citations: 53     Fields:    Translation:HumansCells
    61. Bai TR, Zhou D, Aubert JD, Lizee G, Hayashi S, Bondy GP. Expression of beta 2-adrenergic receptor mRNA in peripheral lung in asthma and chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 1993 Mar; 8(3):325-33. PMID: 7680566.
      Citations: 6     Fields:    Translation:HumansCells
    62. Human dendritic cells in cancer. 121-145.
    63. Rapid tumor regression in an Asian lung cancer patient following personalized neo-epitope peptide vaccination. OncoImmunology. 5.
    64. Forging a link between oncogenic signaling and immunosuppression in melanoma. OncoImmunology. 2.
    65. Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target. Leukemia.
    66. BRAFV600E co-opts a conserved MHC class I internalization pathway to diminish antigen presentation and CD8+ T-cell recognition of melanoma. Cancer immunology research. 3:602-609.
    67. Strong emerging rationale for combining oncogene-targeted agents with immunotherapy. OncoImmunology. 2.
    68. NLRC5/MHC class I transactivator is a target for immune evasion in cancer. Proceedings of the National Academy of Sciences of the United States of America. 113:5999-6004.
    69. Next-generation sequencing of Chinese stage IV lung cancer patients reveals an association between EGFR mutation status and survival outcome. Clinical Genetics.
    70. Peptide/MHC tetramer-based sorting of CD8 T cells to a Leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire. Cancer immunology research. 3:228-235.
    71. Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma. Sarcoma. 2015.
    72. Trouble at the core. OncoImmunology. 5.
    73. Endogenous t-cell therapy. Cancer Journal (United States). 21:492-500.
    74. Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer. OncoImmunology. 2.
    75. Cancer Discovery. 6:202-216.
    76. Cancer and the Cellular Immune Response.
    LIZEE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (327)
    Explore
    _
    Co-Authors (75)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _